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Abstract
Background: The emergence of Plasmodium falciparum resistance to most currently used anti-malarial drugs is a
major problem in malaria control along the Thai-Myanmar and Thai-Cambodia borders. Quinine (QN) with
tetracycline/doxycycline has been used as the second-line treatment for uncomplicated falciparum malaria. In
addition, QN monotherapy has been the first-line treatment for falciparum malaria in pregnant women. However,
reduced in vitro and in vivo responses to QN have been reported. To date, a few genetic markers for QN
resistance have been proposed including Plasmodium falciparum chloroquine resistance transporter (pfcrt), P.
falciparum multidrug resistance 1 (pfmdr1), and P. falciparum Na
+/H
+ exchanger (pfnhe-1). This study was to
investigate the role of the pfmdr1 and pfnhe-1 gene on in vitro QN sensitivity in Thai isolates of P. falciparum.
Methods: Eighty-five Thai isolates of P. falciparum from the Thai-Myanmar and Thai-Cambodia borders from 2003-
2008 were determined for in vitro QN sensitivity using radioisotopic assay. Polymorphisms of the pfmdr1 and pfnhe-
1 gene were determined by PCR-RFLP and sequence analysis. Associations between the in vitro QN sensitivity and
the polymorphisms of the pfmdr1 and pfnhe-1 gene were evaluated.
Results: The mean QN IC50 was 202.8 nM (range 25.7-654.4 nM). Only four isolates were QN resistant when the
IC50 of >500 nM was used as the cut-off point. Significant associations were found between the pfmdr1 mutations
at codons N86Y and N1042D and in vitro QN sensitivity. However, no associations with the number of DNNND,
DDNNNDNHNDD, and NHNDNHNNDDD repeats in the microsatellite ms4760 of the pfnhe-1 gene were identified.
Conclusion: Data from the present study put doubt regarding the pfnhe-1 gene as to whether it could be used as
the suitable marker for QN resistance in Thailand. In contrast, it confirms the influence of the pfmdr1 gene on in
vitro QN sensitivity.
Background
The emergence of anti-malarial resistance in Plasmo-
dium falciparum is a major public health threat world-
wide, especially in tropical developing countries. The
situation of multidrug-resistant falciparum malaria is
most serious along the Thai-Myanmar and Thai-
Cambodia borders [1]. To handle this situation, WHO
recommends artemisinin derivative-based combination
treatment (ACT) for the treatment of uncomplicated
falciparum malaria [2]. Artesunate-mefloquine combina-
tion has been used as the first-line treatment in Thai-
land for more than 15 years [3]. Quinine (QN)-
tetracycline/doxycycline has been used as the second-
line treatment for uncomplicated falciparum malaria in
Thailand. In addition, QN monotherapy is the first-line
treatment for pregnancy [3,4]. Unfortunately reduced in
vitro and in vivo response to QN has been reported in
Southeast Asia [5,6]. Investigations have been carried
out to identify the mechanisms of QN resistance. At
least three candidate genes including Plasmodium falci-
parum chloroquine resistance transporter (pfcrt), Plas-
modium falciparum multidrug resistance 1 (pfmdr1),
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+/H
+ exchanger (pfnhe-
1) have been linked to reduced QN sensitivity [7-12].
Cooper et al. (2002) showed the association between the
pfcrt mutation at codon 76 and QN sensitivity [7]. In
addition, recent studies have shown that parasites con-
taining a novel mutation in the pfcrt gene, Q352K/R,
C350R, altered QN sensitivity [8,9]. Concerning the
pfmdr1 gene, it has been shown that both mutations
and copy number influenced in vitro QN sensitivity
[10-12]. Using quantitative trait loci on the genetic cross
of HB3 and Dd2 strains, an additional candidate gene,
pfnhe-1, for QN resistance was identified [13]. This gene
encodes a 226 kDa parasite plasma membrane protein
containing 12 transmembraned o m a i n s ,a n d3m i c r o s a -
tellite regions, msR1, ms3580 and ms4760. Variations in
QN susceptibilities between different parasite strains
have also been linked to repeat polymorphisms in the
microsatellite locus ms4760 of pfnhe-1 [13]. A few stu-
dies showed that the number of DNNND,
DDNNNDNHNDD, and NHNDNHNNDDD repeats in
the microsatellite ms4760 influenced in vitro QN sensi-
tivity [14-19]. However, there is a lack of consensus
regarding the specific nature of these associations
[20-25]. For instance, while some studies report an asso-
ciation between reduced susceptibility to QN and an
increase in the number of ‘DNNND’ repeats in ms4760
[15,18,19], others could not verify this association
[22-24], or found that two DNNND repeats was the
optimal number for conferring a reduction in QN sensi-
tivity [17]. Moreover, amplification of a second ms4760
repeat ‘NHNDNHNNDDD’ has been linked to increases
in the parasite’s susceptibility to QN [15,18,19]. How-
ever, the reverse association has also been reported [22],
and several studies have failed to confirm either of these
findings [23,24]. Considering the situation of multidrug-
resistant P. falciparum in Thailand, determination of the
molecular basis of QN resistance is crucial to be able to
monitor parasite resistance. This study was to investi-
gate the influence of the pfmdr1 and pfnhe-1 genes on
in vitro QN sensitivity of Thai isolates of P. falciparum
from both the Thai-Myanmar and Thai-Cambodia
borders.
Methods
Plasmodium falciparum strains and cultivation
The 85 isolates of P. falciparum used in this study
were collected from patients with uncomplicated falci-
parum malaria, who attended malaria clinics and hos-
pitals in malaria endemic areas along the Thai-
Myanmar (Kanchanaburi and Ranong) and Thai-Cam-
bodia (Chantaburi and Srisaket) borders from 2003 to
2008. The research protocol was reviewed and
approved by the Ethics Committee of the Royal Thai
Army Medical Department. Parasites were maintained
in continuous cultures using a modification of the
method of Trager and Jensen [26].
In vitro sensitivity assays
QN sensitivity of P. falciparum isolates was determined
by measurement of [3H] hypoxanthine incorporation
into parasite nucleic acids as previously described [27].
Drug IC50 (i.e. concentration of a drug which inhibits
parasite growth by 50%) was determined from the log
dose/response relationship as fitted by GRAFIT (Eritha-
cus Software, Kent, England).
Genotypic characterization for pfmdr1 and pfnhe-1 genes
Parasite DNA was extracted using the Chelex-resin
method [28]. Five microliters of DNA preparation was
used for a 25 μl PCR reaction. Mutations in the pfmdr1
gene were determined by the nested PCR and restriction
endonuclease digestion method developed by Duraisingh
et al. for detection of the mutations at codons 86, 184,
1034, 1042 and 1246. K1 and 7G8 strain were used as
positive controls [29]. The pfmdr1 gene copy number
was determined by TaqMan real-time PCR (ABI
sequence detector 7000; Applied Biosystems) as devel-
oped by Price et al.[ 3 0 ] .T h eK 1a n dD d 2c l o n ec o n -
taining 1 and 4 pfmdr1 copies, respectively was used as
the reference DNA sample. The pfmdr1 and b-tubulin
amplification reactions were run in duplicate. Relative
pfmdr1 copy number was assessed as previously
described. PCR amplification for the pfnhe-1 ms4760
microsatellite was performed as previously described
[14]. DNA purification and DNA sequencing were con-
ducted by Bioservice Unit, Bangkok, Thailand.
Sequences were analyzed for the number of DNNND,
DDNNNDNHNDD, and NHNDNHNNDDD repeats in
the pfnhe-1 ms4760 microsatellite by BioEdit sequence
alignment editor (version 7.0.9.0).
Statistical analysis
Data were analysed by SPSS for Windows version 18
(SPSS Inc., Chicago, IL). The SPSS license number is
ID5071846. The QN IC50 of each isolate was the mean
IC50 of three independent experiments. Each experiment
was carried out in triplicate. Normally distributed IC50
data were assessed by the Kolmogorov Smirnov test.
Differences among parasites with different genotypes
was analysed by Chi square and Fisher’s exact test. Cor-
relations between QN IC50 and the pfmdr1 copy num-
ber and the number of DNNND, DDNNNDNHNDD,
and NHNDNHNNDDD repeats in the pfnhe-1 ms4760
microsatellite were assessed by Pearson’s correlation.
Differences of the mean QN IC50 among parasites from
different groups were analyzed by Independent t test or
One-way ANOVA. Post Hoc test (Scheffe) for multiple
comparisons was used to test for differences among
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<0.05.
Results
In vitro QN sensitivity
Characteristics of parasite isolates are presented in Table
1. The mean IC50 (± SD) for QN was 202.8 ± 123.3 nM
(range 25.7-654.4 nM). QN IC50si nt h i sp o p u l a t i o no f
isolates were normally distributed. No significant differ-
ences were found between QN IC50 of parasites isolated
from the Thai-Cambodia and Thai-Myanmar borders (p
= 0.641, Independent t test). Of 85 isolates, only 4
(4.7%) isolates exhibited QN IC50 of >500 nM. Charac-
terization of the four QN-resistant P. falciparum isolates
is shown in Table 2.
Characterization of the pfmdr1 and pfnhe-1 genes
Characterization of the pfmdr1 gene of 85 isolates is
shown in Table 1. Approximately 60% of the parasite
isolates contained the pfmdr1 184F allele. Determination
of the pfmdr1 gene copy number showed that these iso-
lates contained pfmdr1 copy numbers with a mean of
2.0 (range 0.7-5.6). The pfmdr1 184F allele was more
common in the parasites isolated from the Thai-Cambo-
dia border compared with those from the Thai-Myan-
mar border. In contrast, the parasites isolated from the
Thai-Myanmar border had significantly higher copy
numbers. A total of 81 isolates were characterized for
polymorphisms in the number of DNNND,
DDNNNDNHNDD, and NHNDNHNNDDD repeats in
the pfnhe-1 ms4760 microsatellite (Table 3). The most
common number of DNNND, DDNNNDNHNDD, and
Table 1 In vitro sensitivity to QN and distribution of pfmdr1 polymorphisms of the 85 adapted parasites from Thai-
Myanmar and Thai-Cambodia areas
Area No. Mean QN Mean pfmdr1 mutations
IC50 (nM) pfmdr1 copy number 86Y 184F 1034C 1042D 1246Y
Thai- Myanmar 37 209.9 ± 117.1 2.9 ± 1.4* 6 (16.2%) 15 (40.5%) 4 (10.8%) 4 (10.8%) -
Thai- Cambodia 48 197.2 ± 128.9 1.2 ± 0.7 9 (18.8%) 38 (79.2%)** 10 (20.8%) 13 (24.1%) -
Total 85 202.8 ± 123.3 2.0 ± 1.3 15 (17.6%) 53 (61.4%) 14 (16.5%) 17 (20.0%) -
* Significant difference between two areas determined by Independent t test (p < 0.001)
** Significant difference between two areas determined by Chi square test (p < 0.001)
Table 2 Characterization of the four QN-resistant isolates
of Plasmodium falciparum
SK20 SK22 MR2 KB12
Origin Srisaket Srisaket Chantaburi Kanchanaburi
QN IC50 (nM) 521.8 503.0 530.6 654.4
Pfmdr1 mutations
N86Y N N N N
Y184F F F F F
S1034C S S S C
N1042D N N N D
D1246Y D D D D
Pfmdr1 copy number 0.8 0.9 1.2 2.0
Pfnhe-1
DNNND repeats 3 4 1 3
DDNNNDNHNDD
repeats
12 1 1
NHNDNHNNDDD
repeats
11 0 1
Table 3 Comparison of in vitro QN sensitivity among
Plasmodium falciparum with different pfmdr1and pfnhe-1
genotypes
Parasite genotypes No. (%) Mean QN IC50 p value
(nM)
pfmdr1
86 N86 70 (82.4) 216.5 ± 127.5 0.025*
86Y 15 (17.6) 138.3 ± 76.1
184 Y184 32 (37.7) 160.4 ± 93.6 0.013*
184F 53 (62.3) 228.3 ± 132.6
1034 S1034 71 (83.5) 194.1 ± 114.0 0.144
1034C 14 (16.5) 246.9 ± 160.5
1042 N1042 68 (80) 185.8 ± 113.8 0.010*
1042D 17 (20) 270.5 ± 139.9
Copy no. <3 69 (81.2) 195.8 ± 132.2 0.284
≥ 3 16 (18.8) 232.7 ± 68.8
pfnhe-1
DNNND repeats 0 1 (1.2) 183.6 0.958
1 3 (3.7) 246.1 ± 147.1
2 5 (6.2) 163.7 ± 44.2
3 26 (32.1) 203.0 ± 155.3
4 39 (48.2) 213.0 ± 108.6
5 7 (8.6) 195.9 ± 92.0
DDNNNDNHNDD repeats 0 3 (3.7) 115.7 ± 71.3 0.049**
1 14 (17.3) 272.6 ± 193.1
2 64 (79.0) 195.8 ± 102.4
NHNDNHNNDDD repeats 0 9 (11.1) 196.4 ± 137.6 0.378
1 70 (86.4) 210.8 ± 124.2
2 2 (2.5) 87.0 ± 47.4
* Significant difference determined by Independent t test
* Significant difference determined by One-way ANOVA
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1 (86.4%). Genotypic characterization of the four QN-
resistant isolates is shown in Table 2.
The association between in vitro quinine sensitivity and
the pfmdr1 and pfnhe-1 genes
No correlation was found between QN IC50 and the
pfmdr1 copy number (r = 0.099, p = 0.367) and the num-
ber of DNNND (r =0 . 0 1 7 ,p = 0.880), DDNNNDNHNDD
(r = -0.76, p = 0.503), and NHNDNHNNDDD (r = -0.420,
p = 0.711) repeats in the pfnhe-1 ms4760 microsatellite.
Table 3 shows the in vitro QN sensitivities of these
adapted Thai isolates containing different pfmdr1 geno-
types and different number of DNNND,
DDNNNDNHNDD, and NHNDNHNNDDD repeats in
the pfnhe-1 ms4760 microsatellite. Parasite isolates with
pfmdr1 184F and 1042D showed significantly higher QN
IC50 than those containing pfmdr1 184Y and 1042N,
respectively. In contrast, parasites having pfmdr1 86Y
exhibited significantly lower QN IC50 than those having
pfmdr1 86N. Parasites containing different pfmdr1 copy
number and the number of DNNND and
NHNDNHNNDDD repeats in the pfnhe-1 ms4760 micro-
satellite showed no significant difference in the mean QN
IC50. When the parasites were categorized into subgroups
according to their copy number of the pfmdr1gene, using
3 copies as the cut-off point gave the greatest difference of
the QN IC50 between 2 groups compared to other figures.
However no significant difference was detected. These
parasites were also classified into subgroups with a differ-
ent number of DNNND repeats. No significant difference
were found between QN IC50 of parasites containing ≥2
and less repeats (204.9 ± 121.5 nM & 230.5 ± 204.1 nM, p
= 0.692), ≥3 and less repeats (207.7 ± 124.7 nM & 207.7 ±
124.7 nM, p = 0.748) or ≥4 and less repeats (210.4 ± 105.5
nM & 200.5 ± 148.1 nM, p = 0.728). Although analysis by
One-way ANOVA showed a significant difference of QN
IC50 in the parasites with a different number of
DDNNNDNHNDD repeats, multiple comparison showed
no significant difference between groups.
According to their pfmdr1 haplotypes, parasites were
classified into five groups (Table 4), i.e., the isolates con-
taining the pfmdr1 86Y, 1042D, 184F with copy number
<3, 184Y with copy number <3 and 184Y with copy
number ≥3. Significant differences of QN IC50 were
found among these groups (p = 0.019, One-way
ANOVA). Multiple comparison indicated that only para-
sites containing pfmdr1 1042D were significantly less
sensitive to QN than parasites containing pfmdr1 86Y (p
= 0.048).
Discussion
In the present study, using the IC50 of >500 nM as the
cut-off point for in vitro QN resistance, only 4.7% (4/85)
exhibited QN resistance. Although a higher cut-off
point at 800 nM has been proposed, no parasite isolate
was found showing QN IC50 of >800 nM. This result is
similar to those previous reports showing that most
Thai isolates of P. falciparum were QN sensitive
[6,31,32]. However data from these studies might not be
comparable since different methods including schizont
maturation inhibition, isotopic and SYBR green 1 based
fluorescence assays were used for the determination of
QN IC50. In addition, since culture-adapted isolates
were used in some studies including the present study,
specific phenotypes might be selected during the adapta-
tion process. The situation of QN resistance in Thailand
is less serious than those found in mefloquine and
chloroquine. This may be due to a lower drug pressure
of QN since it has a shorter half life. However, a decline
in QN sensitivity of P. falciparum isolated from the
Thai-Myanmar border has been indicated in recent
study [6].
All parasite isolates in this study contained chloro-
quine-resistant haplotype, CVIET of the pfcrt. The asso-
ciation between in vitro QN sensitivity and
polymorphisms of the pfmdr1 gene, but not the pfnhe-1
gene, was identified. Although a genetic cross study
indicated that QN sensitivity can be modulated by the
pfnhe-1 gene [13], the role of the pfnhe-1 gene as a
molecular marker for QN resistance is still controversial.
Some but not all in vitro and in vivo studies identified
the association between DNNND, DDNNNDNHNDD,
and NHNDNHNNDDD repeats of the pfnhe-1 ms4760
microsatellite and QN sensitivity and treatment out-
come, respectively [14-19,23-25]. Nearly half of Thai iso-
lates in the present study contained 4 DNNND repeats
while most parasites from other areas in Southeast Asia
including Vietnam and the China-Myanmar border con-
tained 3 DNNND repeats [18,19]. Similar to these 2 stu-
dies, most isolates in the present study contained 1
repeat of NHNDNHNNDDD. The studies with positive
association usually showed that parasites with 2 or more
than 2 DNNND repeats had a significantly reduced QN
sensitivity compared with those with 1 repeat. This asso-
ciation has been found in the studies from Vietnam and
the China-Myanmar border as well [18,19]. In contrast,
no significant difference of QN IC50 between parasites
containing ≥2 and less DNNND repeats was identified.
Inconsistent findings of the association between the
response to QN and pfnhe-1 gene might be due to its
interaction with other genes such as pfcrt and pfmdr1.
This postulation has been provided to explain the result
of a knockdown pfnhe-1 expression resulting in
increased QN sensitivity in 2 of 3 parasite lines [16]. In
addition, a recent study in Kenya found no significant
difference of QN IC50 among parasites with different
DNNND repeats [17]. However parasites containing 2
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QN sensitivity. When the QN IC50 of the parasites con-
taining a similar number of DNNND repeats in the
pfnhe-1 ms4760 microsatellite with different 86 alleles in
the pfmdr1 gene was compared, no significant difference
of QN IC50 among these parasites was identified (data
not shown). In addition, no significant correlations
between the number of DDNNNDNHNDD, and
NHNDNHNNDDD repeats of the pfnhe-1 ms4760
microsatellite and in vitro QN sensitivity were found.
Since there were only four isolates exhibiting reduced
QN susceptibility, this may be restrictive for identifica-
tion or validation of these new markers.
In contrast to the pfnhe-1 gene, in vitro QN sensitivity
was significantly associated with the mutations in the
pfmdr1 gene in these Thai isolates. The parasites con-
taining the pfmdr1 184F and 1042D allele showed less
sensitivity to QN while those with the pfmdr1 86Y
exhibited increased QN sensitivity. However, when the
parasites were categorized according to their haplotypes
of the pfmdr1 gene, the pfmdr1 86Y and 1042D allele
influenced QN sensitivity. Compelling evidence for a
significant role of N1042D mutation on in vitro QN
sensitivity has been shown in a few studies using allelic
exchange strategies [10,11]. Reed et al. [10] showed that
insertion of the pfmdr1 gene containing the 1034C,
1042D and 1246Y alleles made a QN - sensitive parasite
become more resistant to QN [10]. Conversely, a QN
-resistant line became more sensitive to QN after these
alleles were removed. More recently, a study by Sidhu et
al. (2005) identified that a single mutation, the N1042D,
could modulate the parasites become less sensitive to
QN [11]. Unlike the N1042D mutation, the functional
role of the N86Y mutation on QN sensitivity has been
explored by expression of the pfmdr1 gene in a hetero-
logous system, Xenopus oocytes [33]. Substituting the
asparagines (N) at position 86 for tyrosine (Y) resulted
in a loss of QN transport ability. Since the site of QN
action is in the food vacuole, [34,35] transport ability of
the wild-type Pgh1 reduces drug concentration in the
food vacuole, and consequently results in decreased QN
susceptibility. This finding is compatible to that found
in a few studies using parasites isolated from Southeast
Asia, including the present study showing that the para-
site isolates containing the pfmdr1 86Y allele showed
more sensitive to QN [20,32]. However, a contrary
result was shown in the study of parasite isolates from
Kenya [17]. The decrease in QN susceptibility was asso-
ciated with the pfmdr1 86Y allele in parasites harbour-
ing the two DNNND repeats in the pfnhe-1 ms4760
microsatellite. Since reduced susceptibility to QN appear
to be governed by a number of proteins whose contribu-
tions vary between strains. The contrasting findings
might be explained by different variations in genetic
background of parasites from different geographical
areas. The influence of the pfmdr1 copy number on QN
sensitivity has been confirmed by the study of Sidhu et
al. using the knockdown strategy [12]. A few studies of
parasite isolates from the Thai-Myanmar border also
showed the influence of pfmdr1 copy number on in
vitro QN sensitivity. However, this association has not
been identified in some studies [21,22]. In this study, no
association between the pfmdr1 copy number and in
vitro QN sensitivity neither in parasites from the Thai-
Myanmar nor the Thai-Cambodia border was identified.
In conclusion, the present study confirms the involve-
ment of the pfmdr1 gene in QN sensitivity. Both N86Y
and N1042D mutations significantly modulate in vitro
response to QN. Although previous studies from South-
east Asia including Vietnam and China-Myanmar bor-
der have demonstrated that the pfnhe-1 gene is involved
in QN sensitivity, the present study showed no associa-
tion. This has raised doubt regarding the pfnhe-1 gene
as to whether it could be used as the suitable marker
for QN resistance in Thailand.
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